Reumatoloxía
Hospital de Santa Maria
Lisboa, PortugalPublicacións en colaboración con investigadores/as de Hospital de Santa Maria (10)
2023
-
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
Journal of Rheumatology, Vol. 50, Núm. 8, pp. 1009-1019
2021
-
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Annals of the Rheumatic Diseases, Vol. 80, Núm. 11, pp. 1410-1418
2020
2019
-
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)
Pharmacogenomics Journal
-
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients
Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96
-
Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium
Scientific Reports, Vol. 9, Núm. 1
2015
-
Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: A two-stage case-control study
Pharmacogenetics and Genomics, Vol. 25, Núm. 9, pp. 432-443
-
Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: A multicenter study
Pharmacogenetics and Genomics, Vol. 25, Núm. 7, pp. 323-333
2013
2011
-
Treating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire
Annals of the Rheumatic Diseases, Vol. 70, Núm. 11, pp. 1999-2002